Suscribirse

Impact of ultra-low dose CT acquisition on semi-automated RECIST tool in the evaluation of malignant focal liver lesions - 29/07/20

Doi : 10.1016/j.diii.2020.05.003 
A. Hamard , J. Frandon, A. Larbi, J. Goupil, H. De Forges, J.-P. Beregi, J. Greffier
 Department of Medical Imaging, CHU of Nîmes, University of Montpellier, Medical Imaging Group Nîmes, EA 2415, 30029 Nîmes cedex 9, France 

Corresponding author at: Department of Radiology, EA 2415, Medical Imaging Group, Nîmes University Hospital, Place du Professeur-Robert-Debré, 30029 Nîmes, France.Department of Radiology, EA 2415, Medical Imaging Group, Nîmes University HospitalPlace du Professeur-Robert-DebréNîmes30029France

Bienvenido a EM-consulte, la referencia de los profesionales de la salud.
Artículo gratuito.

Conéctese para beneficiarse!

Highlights

Dosimetric values are significantly reduced by more than 50% with ultra-low dose CT protocol compared to standard dose CT protocol.
Semi-automated RECIST tool shows good performances using an ultra-low dose CT protocol.
Semi-automated RECIST tool can be used in routine with an ultra-low dose CT protocol for the follow-up of patients with known malignant focal liver lesions.

El texto completo de este artículo está disponible en PDF.

Abstract

Purpose

To compare the evaluation of malignant focal liver lesions (FLLs) using a semi-automated RECIST tool with a standard and an ultra-low dose (ULD) computed tomography (CT) protocol.

Materials and methods

Thirty-four patients with malignant FLLs underwent two abdominal-pelvic CT examinations one using a standard protocol and one using an ULD protocol. There were 23 men and 11 women with a mean age 64.3±14.4 (SD) years (range: 22–91 years). Dosimetric indicators were recorded, and effective dose was calculated for both examinations. Mean malignant FLL attenuation, image noise and contrast-to-noise-ratio (CNR) were compared. The largest malignant FLL per patient was evaluated using the semi-automated RECIST tool to determine longest axis length, longest orthogonal axis length, volume and World Health Organisation area.

Results

Dosimetric values were significantly reduced by −56% with ULD compared to standard protocol. No differences in mean malignant FLL attenuation values were found between the two protocols. Image noise was significantly increased for all locations (P<0.05) with ULD compared to standard protocol, and CNR was significantly reduced (P<0.05). On the 34 malignant FLLs analyzed, six semi-automated shapes non-concordant with radiologist's visual impression were highlighted with the software, including one FLL (1/34; 3%) with standard CT acquisition only, three FLLs (3/34; 9%) with ULD CT acquisition only and two FLLs (2/34; 6%) with both CT acquisitions. After manual editing, the concordance of the values of the studied criteria between both acquisitions was good and no significant difference was reported.

Conclusion

Semi-automated RECIST tool demonstrates good performances using ULD CT protocol. It could be used in routine clinical practice with a ULD protocol for follow-up studies in patients with known malignant FLL.

El texto completo de este artículo está disponible en PDF.

Keywords : Liver, Computed X-ray tomography, Artificial intelligence, Response evaluation criteria in solid tumours (RECIST), Low dose CT protocol

Abbreviations : BMI, CNR, CI, CT, CTDIvol, DLP, ED, EASL, FLL, HU, IR, iRECIST, mAseff, mRECIST, MRI, R, RECIST, ROI, SAFIRE, SD, ULD, WHO


Esquema


© 2020  Société française de radiologie. Publicado por Elsevier Masson SAS. Todos los derechos reservados.
Añadir a mi biblioteca Eliminar de mi biblioteca Imprimir
Exportación

    Exportación citas

  • Fichero

  • Contenido

Vol 101 - N° 7-8

P. 473-479 - juillet 2020 Regresar al número
Artículo precedente Artículo precedente
  • Arterial endofibrosis in endurance athletes: Prospective comparison of the diagnostic accuracy of intra-arterial digital subtraction angiography and computed tomography angiography
  • L. Perrier, P. Feugier, C. Goutain-Majorel, N. Girouin, R. Boutier, M. Papillard, M. Bedel, M. Rabilloud, O. Rouvière
| Artículo siguiente Artículo siguiente
  • Prospective assessment of reproducibility of three-dimensional ultrasound for fetal biometry
  • G. Ambroise Grandjean, P. Berveiller, G. Hossu, P. Noble, M. Chamagne, O. Morel

Bienvenido a EM-consulte, la referencia de los profesionales de la salud.

Mi cuenta


Declaración CNIL

EM-CONSULTE.COM se declara a la CNIL, la declaración N º 1286925.

En virtud de la Ley N º 78-17 del 6 de enero de 1978, relativa a las computadoras, archivos y libertades, usted tiene el derecho de oposición (art.26 de la ley), el acceso (art.34 a 38 Ley), y correcta (artículo 36 de la ley) los datos que le conciernen. Por lo tanto, usted puede pedir que se corrija, complementado, clarificado, actualizado o suprimido información sobre usted que son inexactos, incompletos, engañosos, obsoletos o cuya recogida o de conservación o uso está prohibido.
La información personal sobre los visitantes de nuestro sitio, incluyendo su identidad, son confidenciales.
El jefe del sitio en el honor se compromete a respetar la confidencialidad de los requisitos legales aplicables en Francia y no de revelar dicha información a terceros.


Todo el contenido en este sitio: Copyright © 2025 Elsevier, sus licenciantes y colaboradores. Se reservan todos los derechos, incluidos los de minería de texto y datos, entrenamiento de IA y tecnologías similares. Para todo el contenido de acceso abierto, se aplican los términos de licencia de Creative Commons.